Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PI3K family modulators(Phosphatidylinositol 3-kinase family modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Mekanistic Therapeutics LLCStartup |
Active Organization Mekanistic Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Diseases | Discovery | US | Mekanistic Therapeutics LLCStartup | 27 Jun 2024 |
Sarcoma | Discovery | US | Mekanistic Therapeutics LLCStartup | 27 Jun 2024 |
Squamous Cell Carcinoma of Head and Neck | Discovery | US | Mekanistic Therapeutics LLCStartup | 27 Jun 2024 |